budiodarone: Clinical Trials

1 trial of budiodarone, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 recruiting. 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 21Recruiting 1

Follow budiodarone: new trials by email Literature Review of budiodarone trials Research Report on budiodarone

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dose Escalation Study to Assess Safety, Tolerability, and Efficacy of Budiodarone Treatment With Non-permanent Atrial Fibrillation
Budiodarone 200 mg BID, Budiodarone 400 mg BID, Budiodarone 600 mg BID - Atrial Fibrillation (AF), Paroxysmal AF
Phase 2RecruitingXyra, LLC1002026-08-062026-08-28

Conditions studied

Atrial Fibrillation (1)

Sponsors

Xyra, LLC (1)

Countries

Poland (1)

Top investigators

Peter G Milner, MD, FACC (1)

NIH funding

2025 (1)